Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Psychopharmacology

• Publication date

  2012-04-13

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-013-3172-z
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Dextromethorphan

  2019influential reference
• Dextromethorphan abuse

  2018cited by this paper
• Co-administration of ethanol and nicotine: the enduring alterations in the rewarding properties of nicotine and glutamate activity within the mesocorticolimbic system of female alcohol-preferring (P) rats

  2015influential reference
• Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.

  2012cited by this paper
• Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

  2011cited by this paper
• Dextromethorphan Abuse in Texas, 2000–2009

  2011cited by this paper
• Acute and post-acute behavioral and psychological effects of salvinorin A in humans

  2011cited by this paper
• Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000–2010

  2011cited by this paper
• Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

  2011cited by this paper
• Effect of metabolic blockade on the psychoactive effects of dextromethorphan

  2010cited by this paper
• The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

  2010influential reference
• Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers

  2009cited by this paper
• Dextromethorphan abuse: clinical effects and management.

  2009cited by this paper
• Human hallucinogen research: guidelines for safety

  2008influential reference
• Dextromethorphan

  2008cited by this paper
• The behavioral pharmacology of hallucinogens.

  2008cited by this paper
• Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment

  2007influential reference
• A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder.

  2007cited by this paper
• Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB

  2006cited by this paper
• Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.

  2006cited by this paper
• Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004.

  2006cited by this paper
• The Prevalence of Dextromethorphan Abuse Among High School Students

  2006cited by this paper
• Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.

  2006cited by this paper
• Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

  2005cited by this paper
• Side effects of dextromethorphan abuse, a case series.

  2005cited by this paper
• The Abuse Liability of Dextromethorphan Among Adolescents: A Review

  2005cited by this paper
• PCP: from pharmacology to modelling schizophrenia.

  2005influential reference
• An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers

  2005cited by this paper
• Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.

  2005cited by this paper
• Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography

  2004cited by this paper
• Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey

  2004cited by this paper
• Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.

  2003cited by this paper
• A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.

  2002cited by this paper
• Psychometric assessment of the Hallucinogen Rating Scale.

  2001cited by this paper
• The subjective effects of MDMA and mCPP in moderate MDMA users.

  2001cited by this paper
• NMDA receptor challenge with dextromethorphan – subjective response, neuroendocrinological findings and possible clinical implications

  2000cited by this paper
• Dextromethorphan Challenge in Alcohol-Dependent Patients and Controls

  2000cited by this paper
• Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.

  2000cited by this paper
• Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

  1999cited by this paper
• Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled study

  1999cited by this paper
• Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys

  1999cited by this paper
• Serotonin and Hallucinogens

  1999cited by this paper
• Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study.

  1998cited by this paper
• Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.

  1995cited by this paper
• Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.

  1995cited by this paper
• Discriminative stimulus effects of dextromethorphan in the rat

  1994cited by this paper
• Interactions of dextromethorphan with the N-methyl-D-aspartate receptor-channel complex: single channel recordings.

  1994cited by this paper
• Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

  1994influential reference
• High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel.

  1992cited by this paper
• Dextromethorphan, dysphoria and NMDA receptors. Neuromodulatory effects of dextromethorphan: role of NMDA receptors in responses.

  1990cited by this paper
• The Psychology of Religion: An Empirical Approach

  1986cited by this paper
• Polymorphic dextromethorphan metabolism: Co‐segregation of oxidative O‐demethylation with debrisoquin hydroxylation

  1985cited by this paper
• Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes.

  1984cited by this paper
• Comparison of discriminative and reinforcing effects of ketamine and related compounds in the rhesus monkey.

  1981cited by this paper
• The urinary excretion of dextromethorphan and three metabolites in dogs and humans.

  1980cited by this paper
• The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients

  1977cited by this paper
• Methylenedioxyamphetamine (MDA)–Subjective Effects

  1974cited by this paper
• Psychedelic drugs and mystical experience.

  1969cited by this paper
• Psychedelic drugs and mystical experience.

  1969cited by this paper
• PSYCHOPHARMACOLOGY

  1957cited by this paper

• Neurologic Complications of Recreational Drugs

  2021cites this paper
• Artificial intelligence to detect unknown stimulants from scientific literature and media reports

  2021cites this paper
• Pharmacological assistance for psychotherapy

  2021cites this paper
• Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan

  2020cites this paper
• Steroids, Dissociatives, Club Drugs, Inhalants, and Hallucinogens

  2020cites this paper
• The How and Why of Psychedelics

  2019cites this paper
• New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues

  2019cites this paper
• Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment

  2018cites this paper
• Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition

  2018influential citation
• Drugs to Alter Extracellular Concentration of Glutamate: Modulators of Glutamate Uptake Systems

  2018cites this paper
• TMS-evoked EEG potentials from prefrontal and parietal cortex: reliability, site specificity, and effects of NMDA receptor blockade

  2018cites this paper
• Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution

  2017cites this paper
• Protective effect of Lycium Barbarum polysaccharides on dextromethorphan-induced mood impairment and neurogenesis suppression.

  2017cites this paper
• MK‐801, but not naloxone, attenuates high‐dose dextromethorphan‐induced convulsive behavior: Possible involvement of the GluN2B receptor

  2017cites this paper
• Recreational use of dextromethorphan, "Robotripping"-A brief review.

  2016cites this paper
• Perioperative Dextromethorphan as an Adjunct for Postoperative Pain: A Meta-analysis of Randomized Controlled Trials

  2016cites this paper
• Glutamate Pharmacological Models Relevant to Schizophrenia and Psychosis: Can a Receptor Occupancy Normalization Approach Reduce the Gap between Animal and Human Experiments?

  2016cites this paper
• Misuse of OTC drugs in Poland.

  2016cites this paper
• Rekreacyjne używanie leków dostępnych w odręcznej sprzedaży: odurzanie i doping mózgu

  2015cites this paper
• Chiral analysis of methorphan in opiate-overdose related deaths by using capillary electrophoresis.

  2015cites this paper
• Drugs that Act on the Respiratory Tract

  2014cites this paper
• Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects

  2012cites this paper